Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bread Financial Announces Approval of $200 Million Share Repurchase Program
-
Rezolute to Participate in Upcoming Investor Conferences
-
Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2025 Results
-
DallasNews Rejects Revised Non-Binding Proposal from Affiliate of Alden Global Capital
-
Bancroft Fund Ltd. Declares Distribution of $0.32 per Share
-
Ellsworth Growth and Income Fund Ltd. Declares Distribution of $0.16 per Share
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
-
MasterCraft Boat Holdings, Inc. Reports Fiscal 2025 Results
-
BridgeBio to Participate in September Investor Conferences
-
nCino to Participate in Upcoming Investor Events
-
Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers
-
Keep Our Roads, Waterways and Trails Safe this Labour Day Long Weekend: Drive Sober
-
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
-
Shentel Brings Fiber-to-the-Home Internet to Radford, VA
-
Pet Valu Locks in Lower Prices on Over 100 Pet Products
-
Invivyd to Participate in Upcoming Investor Conferences
-
Western Communities Foundation Opens 2025 Grant Applications to Build Safer, Stronger Communities
-
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
-
Skye Bioscience to Host Virtual KOL Event and Provide Perspectives on Upcoming CBeyond™ Phase 2a Topline Clinical Data Readout
-
Wugen Secures $115 Million to Advance Pivotal Study of First-in-Class Allogeneic CAR-T Therapy, WU-CART-007
-
OBSBOT Powers EWC 2025 in Riyadh with AI-Driven 4K Videography and Scalable Live Production
-
Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference
-
Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences
-
Sionna Therapeutics to Participate in Upcoming September Investor Conferences
-
Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
Inspired Announces Proposed Sale of UK Holiday Parks Business to GENDA Inc.
-
BioXcel Therapeutics Announces SERENITY At-Home Pivotal Phase 3 Safety Trial Met its Primary Endpoint in Support of sNDA Submission for Label Expansion of IGALMI®
-
Mesoblast Financial Results and Corporate Update Webcast
-
CTW to Participate in the Lake Street 2025 BIG9 Conference
-
Destination XL Group, Inc. Reports Second Quarter Financial Results
-
The Lovesac Company Appoints Alan Boehme to Its Board of Directors
-
NEW: Food Allergy Emergency Care Plan Empowers Self-Care and Reduces Health Care Costs
-
Photronics Reports Third Quarter Fiscal 2025 Financial Results
-
TREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal Cancer
-
Avalo Therapeutics to Participate in Upcoming Investor Conferences
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
-
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
-
ECARX Receives ASPICE v4.0 CL3 Certification, Reinforcing Global Expansion and Technology Leadership
-
Quell Therapeutics Establishes World-Class Scientific Advisory Board
-
Bitget Wallet Launches Native Gas-Free Transactions Across Arbitrum, Solana, and TRON
-
AWALL VR Announces Official Launch, Merging Advertising with Cryptocurrency-Powered Video Engagement
-
YieldMax® ETFs Announces Distributions on SMCY, WNTR, ULTY, MSTY, LFGY, and Others
-
Reliance, Inc. Announces Participation at the Jefferies Industrials Conference
-
Form 8.3 - Tritax Big Box Reit Plc
-
Brazil Potash Leadership Invited to Annual Mura Indigenous Cultural Festival
-
Form 8.3 - Life Science REIT Plc
-
Form 8.3 - Empiric Student Property Plc
-
Form 8.3 - Apax Global Alpha Limited
-
Probe Gold Announces Infill Drilling Results with Grades Up to 20.4 g/t Au Over 5.5 Metres (cut) at Novador Project, Quebec
